270 related articles for article (PubMed ID: 31352439)
1. Alpha Globin Gene Mutation: A Major Determinant of Hydroxyurea Response in Transfusion-Dependent HbE-β-Thalassaemia.
Biswas S; Ray R; Roy K; Bandyopadhyay A; Ghosh K; Bhattacharyya M
Acta Haematol; 2019; 142(3):132-141. PubMed ID: 31352439
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia.
Biswas S; Nag A; Ghosh K; Ray R; Roy K; Bandyopadhyay A; Bhattacharyya M
Ann Hematol; 2019 Feb; 98(2):289-299. PubMed ID: 30413899
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
Italia KY; Jijina FF; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
[TBL] [Abstract][Full Text] [Related]
4. α-Haemoglobin stabilising protein expression is influenced by mean cell haemoglobin and HbF levels in HbE/β-thalassaemia individuals.
Lim WF; Muniandi L; George E; Sathar J; Teh LK; Gan GG; Lai MI
Blood Cells Mol Dis; 2012 Jan; 48(1):17-21. PubMed ID: 22079025
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.
Foong WC; Ho JJ; Loh CK; Viprakasit V
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011579. PubMed ID: 27755646
[TBL] [Abstract][Full Text] [Related]
6. A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia.
Yasara N; Wickramarathne N; Mettananda C; Silva I; Hameed N; Attanayaka K; Rodrigo R; Wickramasinghe N; Perera L; Manamperi A; Premawardhena A; Mettananda S
Sci Rep; 2022 Feb; 12(1):2752. PubMed ID: 35177777
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea responses in clinically varied beta, HbE-beta thalassaemia and sickle cell anaemia patients of Eastern India.
Chatterjee T; Chakravarty A; Chakravarty S
Ann Hematol; 2018 May; 97(5):893-898. PubMed ID: 29453624
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype association analysis identifies the role of α globin genes in modulating disease severity of β thalassaemia intermedia in Sri Lanka.
Perera S; Allen A; Silva I; Hapugoda M; Wickramarathne MN; Wijesiriwardena I; Allen S; Rees D; Efremov DG; Fisher CA; Weatherall DJ; Premawardhena A
Sci Rep; 2019 Jul; 9(1):10116. PubMed ID: 31300739
[TBL] [Abstract][Full Text] [Related]
10. Molecular understanding of unusual HbE-β
Jomoui W; Satthakarn S; Panyasai S
Ann Med; 2023; 55(2):2267054. PubMed ID: 37816374
[TBL] [Abstract][Full Text] [Related]
11. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group.
de Silva S; Fisher CA; Premawardhena A; Lamabadusuriya SP; Peto TE; Perera G; Old JM; Clegg JB; Olivieri NF; Weatherall DJ
Lancet; 2000 Mar; 355(9206):786-91. PubMed ID: 10711926
[TBL] [Abstract][Full Text] [Related]
12. The role of heterocellular hereditary persistence of fetal haemoglobin in beta(0)-thalassaemia intermedia.
Chang YP; Littera R; Garau R; Smith KD; Dover GJ; Iannelli S; Cacace E; Contu L
Br J Haematol; 2001 Sep; 114(4):899-906. PubMed ID: 11564083
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea therapy in beta-thalassaemia intermedia: improvement in haematological parameters due to enhanced beta-globin synthesis.
Zeng YT; Huang SZ; Ren ZR; Lu ZH; Zeng FY; Schechter AN; Rodgers GP
Br J Haematol; 1995 Jul; 90(3):557-63. PubMed ID: 7646994
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterisation of beta-globin gene cluster deletions in Chinese using multiplex ligation-dependent probe amplification.
So CC; So AC; Chan AY; Tsang ST; Ma ES; Chan LC
J Clin Pathol; 2009 Dec; 62(12):1107-11. PubMed ID: 19946097
[TBL] [Abstract][Full Text] [Related]
15. Association of alpha hemoglobin-stabilizing protein (AHSP) gene mutation and disease severity among HbE-beta thalassemia patients.
Ray R; Kalantri SA; Bhattacharjee S; Biswas A; Shahab A; Biswas S; Bhattacharyya M
Ann Hematol; 2019 Aug; 98(8):1827-1834. PubMed ID: 31190133
[TBL] [Abstract][Full Text] [Related]
16. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
Darbari DS; Nouraie M; Taylor JG; Brugnara C; Castro O; Ballas SK
Eur J Haematol; 2014 Apr; 92(4):341-5. PubMed ID: 24330217
[TBL] [Abstract][Full Text] [Related]
17. Alpha globin gene numbers: an important modifier of HbE/beta thalassemia.
Sharma V; Kumar B; Kumar G; Saxena R
Hematology; 2009 Oct; 14(5):297-300. PubMed ID: 19843387
[TBL] [Abstract][Full Text] [Related]
18. Alpha thalassaemia and extended alpha globin genes in Sri Lanka.
Suresh S; Fisher C; Ayyub H; Premawardhena A; Allen A; Perera A; Bandara D; Olivieri N; Weatherall D
Blood Cells Mol Dis; 2013 Feb; 50(2):93-8. PubMed ID: 23138098
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
Watanapokasin Y; Chuncharunee S; Sanmund D; Kongnium W; Winichagoon P; Rodgers GP; Fucharoen S
Exp Hematol; 2005 Dec; 33(12):1486-92. PubMed ID: 16338491
[TBL] [Abstract][Full Text] [Related]
20. Severity differences in beta-thalassaemia/haemoglobin E syndromes: implication of genetic factors.
Winichagoon P; Thonglairoam V; Fucharoen S; Wilairat P; Fukumaki Y; Wasi P
Br J Haematol; 1993 Apr; 83(4):633-9. PubMed ID: 7686036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
